Administration of prostaglandin E1 in neonates with critical congenital cardiac defects
- 1 September 1978
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 93 (3) , 481-485
- https://doi.org/10.1016/s0022-3476(78)81171-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- The use of prostaglandin E1 in an infant with interruption of the aortic archThe Journal of Pediatrics, 1977
- Neurological and electroencephalographic changes in newborns treated with prostaglandins E2 and E2Prostaglandins, 1977
- PROSTAGLANDIN E-1 (PGE-1) & PULMONARY VASCULAR RESIS- TANCE IN NEONATAL LAMBSPediatric Research, 1977
- Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.Circulation, 1977
- PROSTAGLANDIN E1 FOR INTERRUPTED AORTIC ARCH IN THE NEONATEThe Lancet, 1976
- E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.Circulation, 1976
- MEDICAL MANIPULATION OF THE DUCTUS ARTERIOSUSThe Lancet, 1975
- Studies on closure of the ductus arteriosus. X. effect of prostaglandinProstaglandins, 1975
- MEDICAL MANIPULATION OF THE DUCTUS ARTERIOSUSThe Lancet, 1975
- The Response of the Ductus Arteriosus to ProstaglandinsCanadian Journal of Physiology and Pharmacology, 1973